Organelle‐Targeting Nanoparticles
Advanced Science · 2025-02 · 12 (7)
DOI: 10.1002/advs.202411720 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Science, online erschienen am 13.01.2025. Verfasst von John Soukar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Interdisiplinary program in Genetics and Genomics, Texas A&M University, College Station, TX, 77843, USA. Hauptthemen laut MEDLINE: Organelles, Nanoparticles, Drug Delivery Systems. Die Arbeit wurde bisher 68-mal zitiert (Crossref) und nennt 173 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIBIB NIH HHS, NIDCR NIH HHS, President's Excellence Fund (X-Grants) from Texas A&M University.
Abstract (Originalsprache)
Organelles are specialized subunits within cells which carry out vital functions crucial to cellular survival and form a tightly regulated network. Dysfunctions in any of these organelles are linked to numerous diseases impacting virtually every organ system in the human body. Targeted delivery of therapeutics to specific organelles within the cell holds great promise for overcoming challenging diseases and improving treatment outcomes through the minimization of therapeutic dosage and off‐target effects. Nanoparticles are versatile and effective tools for therapeutic delivery to specific organelles. Nanoparticles offer several advantageous characteristics, including a high surface area‐to‐volume ratio for efficient therapeutic loading and the ability to attach targeting moieties (tethers) that enhance delivery. The choice of nanoparticle shape, size, composition, surface properties, and targeting ligands depends on the desired target organelle and therapeutic effect. Various nanoparticle platforms have been explored for organelle targeting, such as liposomes, polymeric nanoparticles, dendrimers, and inorganic nanoparticles. In this review, current and emerging approaches to nanoparticle design are examined in the context of various diseases linked to organelle dysfunction. Specifically, advances in nanoparticle therapies targeting organelles such as the nucleus, mitochondria, lysosomes/endosomes, Golgi apparatus, and endoplasmic reticulum are comprehensively and critically discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Interdisiplinary program in Genetics and Genomics, Texas A&M University, College Station, TX, 77843, USA.
- Department of Biomedical Engineering, College of Engineering, Texas A&M University, College Station, TX, 77843, USA.
- Department of Biomedical Engineering, University of Texas at Austin, Austin, TX, 78712, USA.
- Institute of Biomaterials, Drug Delivery and Regenerative Medicine, University of Texas at Austin, Austin, TX, 78712, USA.
- Department of Chemical Engineering, University of Texas at Austin, Austin, TX, 78712, USA.
- Department of Surgery and Perioperative Care, Dell Medical School, University of Texas at Austin, Austin, TX, 78712, USA.
ORCID-Profile: Akhilesh K Gaharwar
Förderung
- NIBIB NIH HHS
- NIDCR NIH HHS
- President's Excellence Fund (X-Grants) from Texas A&M University
- Congressionally Directed Medical Research Programs
- National Institute of Dental and Craniofacial Research
- National Institute of Biomedical Imaging and Bioengineering
Zitieren
APA
Soukar, J., Peppas, N. A., & Gaharwar, A. K. (2025). Organelle‐Targeting Nanoparticles. Advanced Science, 12(7). https://doi.org/10.1002/advs.202411720
Vancouver
Soukar J, Peppas NA, Gaharwar AK. Organelle‐Targeting Nanoparticles. Advanced Science. 2025;12(7). doi:10.1002/advs.202411720
BibTeX
@article{Soukar2025,
author = {Soukar, John and Peppas, Nicholas A and Gaharwar, Akhilesh K},
title = {Organelle‐Targeting Nanoparticles},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {7},
doi = {10.1002/advs.202411720}
}
EUVIMED